Nutex Health Inc
NASDAQ:NUTX

Watchlist Manager
Nutex Health Inc Logo
Nutex Health Inc
NASDAQ:NUTX
Watchlist
Price: 171.72 USD -2.31%
Market Cap: 1.2B USD
Section:
 

Relative Value

The Relative Value of one NUTX stock under the Base Case scenario is hidden USD. Compared to the current market price of 171.72 USD, Nutex Health Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NUTX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.2
P/S
P/S
Price to Sales
1.2
vs History
55
vs Industry
63
Median 3Y
0.7
Median 5Y
1.5
Industry
2.3
Forward
1.2
More Details
10.4
P/E
P/E
Price to Earnings
10.4
vs History
11
vs Industry
Median 3Y
-0.8
Median 5Y
-1.7
Industry
22.4
Forward
10.9
More Details
6.7
P/OCF
P/OCF
Price to OCF
6.7
vs History
41
vs Industry
26
Median 3Y
9.2
Median 5Y
5.6
Industry
14.4
More Details
7.5
P/FCFE
P/FCFE
Price to FCFE
7.5
vs History
44
vs Industry
16
Median 3Y
9.6
Median 5Y
5.3
Industry
21.5
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
20
vs Industry
15
Median 3Y
2.3
Median 5Y
2.4
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
66
vs Industry
51
Median 3Y
1.3
Median 5Y
2.5
Industry
2.5
Forward
1.3
More Details
2.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.4
vs History
77
vs Industry
27
Median 3Y
4.5
Median 5Y
8.6
Industry
5.1
More Details
3.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.6
vs History
47
vs Industry
29
Median 3Y
6.9
Median 5Y
3.5
Industry
12
Forward
3.8
More Details
3.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
3.8
vs History
30
vs Industry
23
Median 3Y
2.8
Median 5Y
-2.7
Industry
17.1
Forward
3.7
More Details
7.4
EV/OCF
EV/OCF
Enterprise Value to OCF
7.4
vs History
57
vs Industry
15
Median 3Y
16.2
Median 5Y
10.5
Industry
14.7
More Details
7.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.6
vs History
47
vs Industry
18
Median 3Y
16.1
Median 5Y
5.7
Industry
18.8
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
31
vs Industry
48
Median 3Y
1
Median 5Y
1.3
Industry
1.8
More Details

Multiples Across Competitors

NUTX Competitors Multiples
Nutex Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Nutex Health Inc
NASDAQ:NUTX
1.2B USD 1.2 10.4 3.6 3.8
US
Veeva Systems Inc
NYSE:VEEV
36.3B USD 11.7 41.9 31.9 33.2
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
22.9B AUD 104 199.1 137.6 137.6
JP
M3 Inc
TSE:2413
1.4T JPY 4.2 30.1 15.3 18.8
US
Doximity Inc
NYSE:DOCS
8.3B USD 13.4 32.9 28.8 29.7
US
Waystar Holding Corp
NASDAQ:WAY
5.8B USD 5.6 51.9 17.2 26.9
SE
Sectra AB
STO:SECT B
48.9B SEK 22.6 82.3 -117.3 -116.2
US
Inspire Medical Systems Inc
NYSE:INSP
3.4B USD 3.9 76.9 61.5 82.6
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
287.9B INR 10.8 59.2 36.9 43
US
Vocera Communications Inc
F:V00
2.4B EUR 12 -331.9 271.2 4 341.9
P/E Multiple
Earnings Growth PEG
US
Nutex Health Inc
NASDAQ:NUTX
Average P/E: 63.8
10.4
53%
0.2
US
Veeva Systems Inc
NYSE:VEEV
41.9
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
199.1
32%
6.2
JP
M3 Inc
TSE:2413
30.1
16%
1.9
US
Doximity Inc
NYSE:DOCS
32.9
18%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
51.9
N/A N/A
SE
Sectra AB
STO:SECT B
82.3
28%
2.9
US
Inspire Medical Systems Inc
NYSE:INSP
76.9
13%
5.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
59.2
30%
2
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -331.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Nutex Health Inc
NASDAQ:NUTX
Average EV/EBITDA: 62.6
3.6
41%
0.1
US
Veeva Systems Inc
NYSE:VEEV
31.9
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
137.6
32%
4.3
JP
M3 Inc
TSE:2413
15.3
14%
1.1
US
Doximity Inc
NYSE:DOCS
28.8
23%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
17.2
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -117.3 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
61.5
80%
0.8
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
36.9
24%
1.5
US
V
Vocera Communications Inc
F:V00
271.2
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Nutex Health Inc
NASDAQ:NUTX
Average EV/EBIT: 476.1
3.8
41%
0.1
US
Veeva Systems Inc
NYSE:VEEV
33.2
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
137.6
31%
4.4
JP
M3 Inc
TSE:2413
18.8
N/A N/A
US
Doximity Inc
NYSE:DOCS
29.7
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
26.9
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -116.2 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
82.6
34%
2.4
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43
27%
1.6
US
V
Vocera Communications Inc
F:V00
4 341.9
N/A N/A

See Also

Summary
NUTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
NUTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NUTX stock valuation using valuation multiples.
Wall Street Estimates
NUTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NUTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.